Conduction System Pacing Versus Biventricular Pacing for Cardiac ResYNChronization (CSP-SYNC)
Cardiac resynchronization therapy (CRT) with biventricular pacing (BiV) is the cornerstone treatment for heart failure patients with ventricular dyssynchrony. Recently, a new concept, conduction system pacing (CSP) with permanent pacing, including His bundle pacing and left bundle branch pacing, has been proposed as a potential alternative to conventional BiV-CRT. The prospective, randomized trial will compare echocardiographic, electrocardiographic, and clinical effects of CSP versus conventional BiV pacing in heart failure patients with reduced ejection fraction (LVEF ≤ 35%), sinus rhythm, and left bundle branch block. Patients will be randomized to either CSP or biventricular pacing study group and followed up for at least 6 months. The study will explore whether CSP is non-inferior to BiV pacing in echocardiographic, electrocardiographic, and clinical outcomes.
⁃ The proposed inclusion criteria represent the minimum recommendations for CRT implantation according to the ESC 2021 guidelines. In addition:
• Sinus rhythm and complete left bundle branch block according to Strauss criteria
• LVEF ≤35%
• NYHA class II-III
• Optimal medical heart failure therapy for at least 3 months before enrollment
• The patient is able to understand and willing to provide a written informed consent
• 18 years of age or older